Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sebastian Dewes"'
Autor:
Caroline Burgard, Florian Rosar, Robert J. Marlowe, Mark Bartholomä, Sebastian Dewes, Andrea Schaefer-Schuler, Johannes Linxweiler, Fadi Khreish, Samer Ezziddin
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2592
“Tumor sink effects”, decreased physiological uptake of radiopharmaceuticals due to sequestration by a tumor, may impact radioligand therapy (RLT) toxicity and dosing. We investigated these effects with prostate-specific membrane antigen (PSMA)-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da9b2045b78b0f2b410f59b1164c18c9
Autor:
Mathias Schreckenberger, Felix Wenner, Mark Bartholomä, Florian Rosar, Gudrun Wagenpfeil, Samer Ezziddin, Manuela A Hoffmann, Sebastian Dewes, Fadi Khreish
Purpose In patients with metastatic castration-resistant prostate cancer (mCRPC) treated with prostate-specific membrane antigen-targeted radioligand therapy (PSMA-RLT), the predictive value of PSMA PET/CT-derived response is still under investigatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1cfb63254cff7d6a59c6999145ea81
Autor:
Fadi Khreish, Andrea Schaefer, Samer Ezziddin, Stephan Maus, Sebastian Dewes, Carsten Ohlmann, Martin Ries, Hendrik Bohnenberger, Mark Bartholomä, Florian Rosar, Johannes Linxweiler
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 47:687-694
There is preliminary evidence for prostate-specific membrane antigen (PSMA) upregulation effects of androgen receptor blockade in prostate cancer. In an attempt to find the best condition for PSMA radioligand therapy in metastatic castration-resistan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76fb8a7a56939cd0f6153176ccc71d81
https://doi.org/10.1007/s00259-019-04674-0
https://doi.org/10.1007/s00259-019-04674-0
Early molecular imaging response assessment based on determination of total viable tumor burden in [
Autor:
Florian, Rosar, Felix, Wenner, Fadi, Khreish, Sebastian, Dewes, Gudrun, Wagenpfeil, Manuela A, Hoffmann, Mathias, Schreckenberger, Mark, Bartholomä, Samer, Ezziddin
Publikováno v:
European journal of nuclear medicine and molecular imaging. 49(5)
In patients with metastatic castration-resistant prostate cancer (mCRPC) treated with prostate-specific membrane antigen-targeted radioligand therapy (PSMA-RLT), the predictive value of PSMA PET/CT-derived response is still under investigation. Early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd16a757bb62780432a76c6251cbc46f
https://pubmed.ncbi.nlm.nih.gov/34725725
https://pubmed.ncbi.nlm.nih.gov/34725725